China Jo-Jo Drugstores, Inc.

CJJD

KYG2124G1203

Drug Retailers

Market Closed - Nasdaq Other stock markets 04:30:00 2024-06-11 pm EDT			5-day change	1st Jan Change
2.42 ^USD	-10.04%		-4.35%	-45.50%

Jun. 11	China Jo-Jo Drugstores Launches $3.4 Million Direct Share Offering	MT
May. 31	China Jo-Jo Drugstores, Inc. Announces Resignation of Pingfan Wu as Member of the Board of Directors	CI

China Jo-Jo Drugstores, Inc. Reports Earnings Results for the Full Year Ended March 31, 2020

July 10, 2020 at 11:50 am EDT

China Jo-Jo Drugstores, Inc. announced earnings results for the full year ended March 31, 2020. For the full year, the company announced sales was USD 117.327 million compared to USD 107.551 million a year ago. Operating loss was USD 7.003 million compared to USD 876,130 a year ago. Net loss was USD 5.813 million compared to USD 926,278 a year ago. Basic loss per share from continuing operations was USD 0.18 compared to USD 0.03 a year ago.

Latest news about China Jo-Jo Drugstores, Inc.

China Jo-Jo Drugstores Launches $3.4 Million Direct Share Offering	Jun. 11	MT
China Jo-Jo Drugstores, Inc. Announces Resignation of Pingfan Wu as Member of the Board of Directors	May. 31	CI
China Jo-Jo Drugstores Shares Slump After $1.5 Million Direct Offering Announcement	Apr. 29	MT
China Jo-Jo Drugstores, Inc. Reports Earnings Results for the Half Year Ended September 30, 2023	Mar. 20	CI
Top Premarket Gainers	Mar. 05	MT
China Jo-Jo Drugstores, Inc. Appoints Caroline Wang as Directors	Feb. 26	CI
China Jo-Jo Drugstores Receives Non-Compliance Notice From Nasdaq	23-06-20	MT
China Jo-Jo Drugstores, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-06-15	CI
Top Midday Gainers	23-04-19	MT
Sector Update: Consumer Stocks Edging Up Late Tuesday	23-04-18	MT
Top Midday Decliners	23-04-18	MT
Sector Update: Consumer Stocks Little Changed Tuesday Afternoon	23-04-18	MT
China Jo-Jo Drugstores Strikes Deal to Sell $7 Million Securities - Shares Slump	23-04-18	MT
China Jo-Jo Drugstores, Inc. Reports Earnings Results for the Half Year Ended September 30, 2022	23-01-20	CI
China Jo-Jo Drugstores Launches $2.6 Million Direct Offering; Shares Fall	23-01-20	MT
Wall Street Set to Open Higher as Earnings Season Accelerates, Ahead of Consumer Sentiment Survey	22-10-14	MT
US Stock Futures Mixed as Earnings Season Accelerates, Ahead of Consumer Sentiment Survey	22-10-14	MT
Top Premarket Decliners	22-10-14	MT
China Jo-Jo Drugstores, Inc. Reports Earnings Results for the Full Year Ended March 31, 2022	22-07-28	CI
China Jo-Jo Drugstores Regains Compliance With Nasdaq's Minimum Bid Price Rule	22-04-27	MT
Top Premarket Decliners	22-04-12	MT
China Jo-Jo Drugstores to Implement 1-for-12 Reverse Stock Split	22-04-06	MT
China Jo-Jo Drugstores Receives Extension to Cure Minimum Bid Price Deficiency	22-01-26	MT
China Jo-Jo Drugstores, Inc. Reports Earnings Results for the Half Year Ended September 30, 2021	22-01-21	CI
China Jo-Jo Drugstores, Inc. Reports Earnings Results for the Full Year Ended March 31, 2021	21-06-29	CI

Chart China Jo-Jo Drugstores, Inc.

Duration

Period

More charts

Company Profile

China Jo-Jo Drugstores Inc, formerly China Jo-Jo Drugstores Holdings Inc, is a China-based retailer and distributor of pharmaceutical and other healthcare products. The Company operates in four business segments. The Retail Drugstores segment sells prescription and over the counter (OTC) medicines, traditional Chinese medicine (TCM), dietary supplements, medical devices, and sundry items to retail customers. The Online Pharmacy segment sells OTC drugs, dietary supplements, medical devices and sundry items through its own and third-party platforms. The Wholesale Business segment includes supplying the Company's own retail drugstores and selling them to other drug vendors and hospitals. The Farming and Selling Herbs segment cultivates selected herbs for sales to other drug vendors.

Sector

Drug Retailers

More about the company

Income Statement Evolution

More financial data

Sector Other Drug Retailers

	1st Jan change	Capi.
CHINA JO-JO DRUGSTORES, INC.	-45.50%	7.42M
WALGREENS BOOTS ALLIANCE, INC.	-38.99%	13.74B
JD HEALTH INTERNATIONAL INC.	-37.47%	10.13B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-16.27%	7.82B
YIFENG PHARMACY CHAIN CO., LTD.	+4.30%	5.82B
MATSUKIYOCOCOKARA & CO.	-15.56%	5.65B
NAHDI MEDICAL COMPANY	-3.36%	4.6B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+67.88%	4.35B
CLICKS GROUP LIMITED	-8.77%	3.79B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-22.93%	3.02B